Curaxis Pharmaceutical Corporation Management to Meet With Shareholders
November 07, 2011 08:30 ET
|
Curaxis Pharmaceutical Corporation
RALEIGH, N.C., Nov. 7, 2011 (GLOBE NEWSWIRE) -- Timothy R. Wright, Chairman and Interim Chief Executive Officer of Curaxis Pharmaceutical Corporation ("Curaxis" or the "Company') (OTCQB:CURX),...
Curaxis Pharmaceutical Corporation Management Working Through Transition Phase and Evaluating Alternatives
August 17, 2011 08:15 ET
|
Curaxis Pharmaceutical Corporation
RALEIGH, N.C., Aug. 17, 2011 (GLOBE NEWSWIRE) -- Timothy R. Wright, Chairman and Interim Chief Executive Officer of Curaxis Pharmaceutical Corporation ("Curaxis" or the "Company") (OTCQB:CURX)...
Curaxis Pharmaceutical Corporation Chief Executive Officer Comments on Recent NIH Research
May 10, 2011 14:14 ET
|
Curaxis Pharmaceutical Corporation
SWAMPSCOTT, Mass., May 10, 2011 (GLOBE NEWSWIRE) -- Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corporation (OTCBB:CURX) ("Curaxis" or the "Company"), commented...
Curaxis' Memryte Named One of the Top 100 Drugs in Development Today by R&D Directions
May 05, 2011 02:30 ET
|
Curaxis Pharmaceutical Corporation
SWAMPSCOTT, Mass., May 5, 2011 (GLOBE NEWSWIRE) -- Curaxis Pharmaceutical Corporation (OTCQB:CURX) ("Curaxis" or the "Company") announced that its lead drug hormone product for Alzheimer's disease,...
Curaxis Pharmaceutical Corp. CEO Patrick S. Smith Comments on Recent Prana Research
March 24, 2011 04:00 ET
|
Curaxis Pharmaceutical Corporation
DURHAM, N.C., March 24, 2011 (GLOBE NEWSWIRE) -- Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp. (OTCBB:CURX) (Frankfurt:8CX), commented today on recent...
Curaxis Pharmaceutical Corp. CEO Patrick S. Smith Comments on Recent New York Times Article "Drug Firms Face Billions in Losses in '11 as Patents End"
March 10, 2011 08:30 ET
|
Curaxis Pharmaceutical Corporation
DURHAM, N.C., March 10, 2011 (GLOBE NEWSWIRE) -- Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp. (OTCQB:CURX) (Frankfurt: 8CX), commented today on an article by...
Curaxis Pharmaceutical Corp. to Meet With Ticino Business Development Office in Lugano, Switzerland
February 14, 2011 02:00 ET
|
Curaxis Pharmaceutical Corporation
DURHAM, N.C., Feb. 14, 2011 (GLOBE NEWSWIRE) -- Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp. (OTCQB:CURX) (Frankfurt:8CX), announced that Curaxis management...
Curaxis Pharmaceutical Corp. Announces New Listing on the Frankfurt Stock Exchange
February 09, 2011 02:00 ET
|
Curaxis Pharmaceutical Corporation
DURHAM, N.C., Feb. 9, 2011 (GLOBE NEWSWIRE) -- Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp. (OTCQB:CURX) (Frankfurt:8CX), today announced Curaxis' new...
Curaxis Pharmaceutical Corp. CEO Patrick S. Smith Comments on Recent Alzheimer's Association Report
February 07, 2011 02:00 ET
|
Curaxis Pharmaceutical Corporation
DURHAM, N.C., Feb. 7, 2011 (GLOBE NEWSWIRE) -- Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp. (OTCBB:CURX), commented today on a new report by the Alzheimer's...
Curaxis Pharmaceutical Management on Roadshow in Europe to Access Capital & Pursue Strategic Partners
February 03, 2011 08:30 ET
|
Curaxis Pharmaceutical Corporation
DURHAM, N.C., Feb. 3, 2011 (GLOBE NEWSWIRE) -- Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp (OTCBB:CURX), confirmed today that Curaxis Management will be in...